Olaparib in Metastatic Breast Cancer: The Impact of Prior Cyclin-Dependent Kinase 4 and 6 Inhibitor Exposure on Efficacy

Journal of Clinical Oncology 2026

View at publisher

Authors: Jinyin Yan, Wei Xiong, Haifeng Cai

DOI: 10.1200/jco-26-00539

Cited by: 1

References: 10

Fields of Study & Subjects

PARP inhibition in cancer therapy Advanced Breast Cancer Therapies Cancer-related Molecular Pathways

References 10